The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

GDR GENEDRIVE PLC ORD 1.5P




 Page 1 of 2

| 1 | 2 | Next

Time/Date Code Headline Source Impact
07:00 20-Jun-2018 GDR Grant for NHS point-of-care test RNS -2.14% Down
11:18 19-Jun-2018 GDR Additional Listing of Shares RNS -2.67% Down
09:25 11-Jun-2018 GDR Completion of Disposal RNS -
16:47 04-Jun-2018 GDR Result of General Meeting RNS -
14:32 17-May-2018 GDR Circular re Proposed Disposal RNS -
17:39 14-May-2018 GDR Proposed disposal for up to £1.9 million in cash RNS +2.13% Up
11:39 10-May-2018 GDR Holding(s) in Company RNS +1.07% Up
07:00 18-Apr-2018 GDR genedrive plc to Present at the UK Investor Show RNS -
07:00 10-Apr-2018 GDR Publication of Genedrive Performance Data in Gut RNS -3.02% Down
09:06 09-Apr-2018 GDR Directorate Change RNS -3.75% Down
08:48 04-Apr-2018 GDR Director/PDMR Shareholding RNS -2.96% Down
07:00 03-Apr-2018 GDR Genedrive® Hepatitis C test in Asia Pacific RNS -1.98% Down
07:00 27-Mar-2018 GDR genedrive signs distribution agreement for India RNS +5.19% Up
15:40 20-Mar-2018 GDR Holding(s) in Company RNS +1.32% Up
07:00 20-Mar-2018 GDR Interim Results RNS +1.32% Up
07:00 13-Mar-2018 GDR Commercial sales of Genedrive® HCV ID Kit begin RNS +8.57% Up
07:00 27-Feb-2018 GDR genedrive Receives Funding for TB Test Development RNS +6.87% Up
07:00 14-Feb-2018 GDR Notice of Results RNS -0.59% Down
11:59 18-Jan-2018 GDR Hardman Res: Hep-C point-of-care test launched RNS +20.00% Up
14:01 17-Jan-2018 GDR Holding(s) in Company RNS +21.20% Up

 Page 1 of 2

| 1 | 2 | Next



Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released
y = instrument's latest 7 closing prices before the news was released, including the day of the release of the news

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank “ - “ next to the line indicating the RNS issue.





Company Information
Company website http://www.genedriveplc...
Company address The Incubator Building, 48 Grafton Street, Manchester, M13 9XX, United Kingdom
FTSE ICB sector Pharmaceuticals & Biotechnology
FTSE ICB subsector Biotechnology
Company market cap, £m* 6.82
Admission date 04 Apr 2007
*The market capitalisation of companies reflects the London listed element only and are approximate. Data provided by FTSE Russell.

Security Information
25-Jun-18
FTSE index FTSE AIM All-Share,FTSE AIM All-Share - Health Care
Market AIM
Market identifier code (MIC) AIMX
Trading service SETSqx
Trading segment ASQ1
Listing category -
Country of share register GB
ISIN GB00B1VKB244
SEDOL B1VKB24
Exchange market size 1,000
Security market cap, £m 6.82



GENEDRIVE share news analysis (GDR)